Health-related quality of life of long-term patients receiving opioid agonist therapy: a nested prospective cohort study in Norway.
Christer Frode AasJørn Henrik VoldSvetlana SkurtveitAaron G LimSabine RuthsKamrul IslamJan Erik AskildsenElse-Marie LøbergLars Thore FadnesKjell Arne Johanssonnull nullPublished in: Substance abuse treatment, prevention, and policy (2020)
The average HRQoL and self-perceived health of OAT patients is significantly lower than that of the general population, and lower than what has been found among other severe somatic and psychiatric conditions. Around 34% had very good HRQoL, higher than average Norwegian values, and around 5% had extremely poor HRQoL.
Keyphrases
- mental health
- end stage renal disease
- healthcare
- newly diagnosed
- ejection fraction
- public health
- chronic kidney disease
- depressive symptoms
- prognostic factors
- physical activity
- peritoneal dialysis
- social support
- stem cells
- dna methylation
- gene expression
- risk assessment
- mesenchymal stem cells
- cell therapy
- human health
- health promotion
- genome wide